Ing. Helmut Schütz

•     
• Forum
• Guidelines
• Articles
• Lectures
• Contact
• Privacy
• Sitemap

Articles

To the right articles are listed in chronological order. Below are articles ordered by topic.

• 🃏 Related to questions commonly asked by regulatory assessors.
• 🆕 Published within the last two weeks.
• 🚧 Article under construction.

To reproduce the articles’ examples is required.

Consider activating JavaScript. Otherwise, you have to be proficient in reading since formulas will not be rendered. Furthermore, the TOC in the left column for navigation will not be available and code-folding not supported. Sorry for the inconvenience.

Power Calculation and Sample Size Estimation

Equivalence

• Parallel Design 255 KB (update 2021-07-05)
• 2×2×2 Design 205 KB (update 2021-07-09)
• Higher-Order Crossover Designs 207 KB (update 2021-07-10)
• Replicate Designs
  • Average Bioequivalence 165 KB (update 2021-04-01)
  • Scaled Average Bioequivalence
    • Highly Variable Drugs / Drug Products
      • RSABE (FDA, China’s CDE) 147 KB (update 2021-07-10)
      • ABEL (all others) 159 KB (update 2021-07-10)
    • Narrow Therapeutic Index Drugs (FDA) 🚧
    • Highly Variable Narrow Therapeutic Index Drugs (FDA) 🚧
  • ABE, RSABE, ABEL: A Comparison 174 KB (update 2021-06-24)
• Two-Stage Designs
  • Group sequential (fixed sample design) 🚧
  • Adaptive (sample size re-estimation) 🃏 🚧

Non-Inferiority, Non-Superiority

• Non-Inferiority 🚧
• Non-Superiority 🚧

Dose Proportionality 🚧

Prospective Power

• Power Analysis 53 KB (update 2021-04-18)
• Sensitivity Analysis 🚧

Noncompartmental Analysis

• Trapezoidal Rules 141 KB (update 2021-06-25)
• Estimation of λ_z 🚧
• Partial AUC 🚧
• Cut-off Times for Biphasic Release Products 🚧
• C_min and C_τ 🚧

Miscellaneous

Statistics

• A Short History of Bioequivalence 🚧
• Carryover – a Never Ending Story 103 KB (update 2021-05-11) 🃏
• Significant Treatment Effect 105 KB (update 2021-04-08) 🃏
• Group ‘Effect’: To Pool or Not to Pool? 🃏 🚧
• Post hoc Power 148 KB (update 2021-07-07) 🃏
• ‘Apparent’ Difference in t_max? 129 KB (update 2021-04-22)
• Inflation of the Type I Error in SABE 🚧
• Simulations 101 127 KB (update 2021-04-11)
• A Rant About ‘Nice Numbers’ 78 KB (update 2021-06-24)
• ‘Precise’ Numbers in Reports 🚧
• Subgroup Analyses 🚧
• Adjusted Indirect Comparisons 🚧

Design Issues

• Tricks and Traps of Washout Phases 🃏 🚧
• SABE planned based on the CV_w from a 2×2×2 Crossover Design 🚧
• Overall Power of Multiple Studies 🚧
• Stratified Randomization. Why? 🚧

Software

• The Wonderland of Representing Numbers in Computers 60 KB (update 2021-06-23)
• 🇷 on Windows 101 45 KB (update 2021-05-03)
• Software Validation 🚧

All articles are licensed under Creative Commons Attribution 4.0 Helmut Schütz 2021.